Trial: 201902011

Phase II Randomized Trial of Radiotherapy with Concurrent and Adjuvant Pembrolizumab (Keytruda®) Versus Concurrent Chemotherapy in Patients with Advanced/Intermediate-Risk p16+ Head and Neck Squamous Cell Carcinoma (KEYCHAIN Trial)

Phase

II

Principal Investigator

Adkins, Douglas

Disease Site

Lip, Oral Cavity and Pharynx

Learn more about this study at: clinicaltrials.gov